KAT7_HUMAN - dbPTM
KAT7_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID KAT7_HUMAN
UniProt AC O95251
Protein Name Histone acetyltransferase KAT7
Gene Name KAT7
Organism Homo sapiens (Human).
Sequence Length 611
Subcellular Localization Nucleus, nucleoplasm . Cytoplasm, cytosol . Nucleus . Associates with replication origins specifically during the G1 phase of the cell cycle (PubMed:18832067).
Protein Description Component of the HBO1 complex which has a histone H4-specific acetyltransferase activity, a reduced activity toward histone H3 and is responsible for the bulk of histone H4 acetylation in vivo. Involved in H3K14 (histone H3 lysine 14) acetylation and cell proliferation (By similarity). Through chromatin acetylation it may regulate DNA replication and act as a coactivator of TP53-dependent transcription. Acts as a coactivator of the licensing factor CDT1. [PubMed: 18832067 Specifically represses AR-mediated transcription.]
Protein Sequence MPRRKRNAGSSSDGTEDSDFSTDLEHTDSSESDGTSRRSARVTRSSARLSQSSQDSSPVRNLQSFGTEEPAYSTRRVTRSQQQPTPVTPKKYPLRQTRSSGSETEQVVDFSDRETKNTADHDESPPRTPTGNAPSSESDIDISSPNVSHDESIAKDMSLKDSGSDLSHRPKRRRFHESYNFNMKCPTPGCNSLGHLTGKHERHFSISGCPLYHNLSADECKVRAQSRDKQIEERMLSHRQDDNNRHATRHQAPTERQLRYKEKVAELRKKRNSGLSKEQKEKYMEHRQTYGNTREPLLENLTSEYDLDLFRRAQARASEDLEKLRLQGQITEGSNMIKTIAFGRYELDTWYHSPYPEEYARLGRLYMCEFCLKYMKSQTILRRHMAKCVWKHPPGDEIYRKGSISVFEVDGKKNKIYCQNLCLLAKLFLDHKTLYYDVEPFLFYVMTEADNTGCHLIGYFSKEKNSFLNYNVSCILTMPQYMRQGYGKMLIDFSYLLSKVEEKVGSPERPLSDLGLISYRSYWKEVLLRYLHNFQGKEISIKEISQETAVNPVDIVSTLQALQMLKYWKGKHLVLKRQDLIDEWIAKEAKRSNSNKTMDPSCLKWTPPKGT
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
10PhosphorylationRRKRNAGSSSDGTED
CCCCCCCCCCCCCCC
25.0230278072
11PhosphorylationRKRNAGSSSDGTEDS
CCCCCCCCCCCCCCC
31.3730278072
11 (in isoform 4)Phosphorylation-31.3724719451
12PhosphorylationKRNAGSSSDGTEDSD
CCCCCCCCCCCCCCC
41.5823663014
15PhosphorylationAGSSSDGTEDSDFST
CCCCCCCCCCCCCCC
41.4323927012
18PhosphorylationSSDGTEDSDFSTDLE
CCCCCCCCCCCCCCC
34.0323927012
18 (in isoform 4)Phosphorylation-34.0324719451
21PhosphorylationGTEDSDFSTDLEHTD
CCCCCCCCCCCCCCC
26.4625849741
22PhosphorylationTEDSDFSTDLEHTDS
CCCCCCCCCCCCCCC
44.5923663014
27PhosphorylationFSTDLEHTDSSESDG
CCCCCCCCCCCCCCC
28.3523927012
29PhosphorylationTDLEHTDSSESDGTS
CCCCCCCCCCCCCCC
36.8421406692
30PhosphorylationDLEHTDSSESDGTSR
CCCCCCCCCCCCCCH
43.8821406692
32PhosphorylationEHTDSSESDGTSRRS
CCCCCCCCCCCCHHH
43.2021406692
35PhosphorylationDSSESDGTSRRSARV
CCCCCCCCCHHHHEE
24.8521406692
36PhosphorylationSSESDGTSRRSARVT
CCCCCCCCHHHHEEE
31.0921406692
39PhosphorylationSDGTSRRSARVTRSS
CCCCCHHHHEEEHHH
21.2223828894
39 (in isoform 3)Phosphorylation-21.2227251275
39 (in isoform 5)Phosphorylation-21.2227251275
43 (in isoform 3)Phosphorylation-21.2027251275
43 (in isoform 5)Phosphorylation-21.2027251275
45PhosphorylationRSARVTRSSARLSQS
HHHEEEHHHHHHHCC
20.9821955146
46PhosphorylationSARVTRSSARLSQSS
HHEEEHHHHHHHCCC
17.7025072903
50PhosphorylationTRSSARLSQSSQDSS
EHHHHHHHCCCCCCC
23.5929255136
50 (in isoform 3)Phosphorylation-23.5927251275
50 (in isoform 4)Phosphorylation-23.5924719451
50 (in isoform 5)Phosphorylation-23.5927251275
52PhosphorylationSSARLSQSSQDSSPV
HHHHHHCCCCCCCCC
26.9629255136
52 (in isoform 3)Phosphorylation-26.9627251275
52 (in isoform 5)Phosphorylation-26.9627251275
53PhosphorylationSARLSQSSQDSSPVR
HHHHHCCCCCCCCCC
30.3029255136
53 (in isoform 3)Phosphorylation-30.3027251275
53 (in isoform 4)Phosphorylation-30.3024719451
53 (in isoform 5)Phosphorylation-30.3027251275
55UbiquitinationRLSQSSQDSSPVRNL
HHHCCCCCCCCCCCH
53.7021890473
56PhosphorylationLSQSSQDSSPVRNLQ
HHCCCCCCCCCCCHH
28.9829255136
57PhosphorylationSQSSQDSSPVRNLQS
HCCCCCCCCCCCHHH
35.3929255136
57 (in isoform 4)Phosphorylation-35.3924719451
58 (in isoform 3)Phosphorylation-32.7927251275
58 (in isoform 5)Phosphorylation-32.7927251275
64PhosphorylationSPVRNLQSFGTEEPA
CCCCCHHHCCCCCCC
28.8925159151
67PhosphorylationRNLQSFGTEEPAYST
CCHHHCCCCCCCCCC
34.8523927012
72PhosphorylationFGTEEPAYSTRRVTR
CCCCCCCCCCCCCCC
22.6923927012
73PhosphorylationGTEEPAYSTRRVTRS
CCCCCCCCCCCCCCC
19.9723927012
74PhosphorylationTEEPAYSTRRVTRSQ
CCCCCCCCCCCCCCC
15.1523927012
77 (in isoform 3)Phosphorylation-4.7425056879
78PhosphorylationAYSTRRVTRSQQQPT
CCCCCCCCCCCCCCC
23.8522964224
80PhosphorylationSTRRVTRSQQQPTPV
CCCCCCCCCCCCCCC
23.9928176443
82UbiquitinationRRVTRSQQQPTPVTP
CCCCCCCCCCCCCCC
53.0929967540
85PhosphorylationTRSQQQPTPVTPKKY
CCCCCCCCCCCCCCC
26.5025159151
85 (in isoform 4)Phosphorylation-26.5024719451
88PhosphorylationQQQPTPVTPKKYPLR
CCCCCCCCCCCCCCC
30.5119664994
88 (in isoform 4)Phosphorylation-30.5124719451
90AcetylationQPTPVTPKKYPLRQT
CCCCCCCCCCCCCCC
56.4226051181
90UbiquitinationQPTPVTPKKYPLRQT
CCCCCCCCCCCCCCC
56.4229967540
92PhosphorylationTPVTPKKYPLRQTRS
CCCCCCCCCCCCCCC
17.3924732914
97PhosphorylationKKYPLRQTRSSGSET
CCCCCCCCCCCCCCC
26.5321955146
99PhosphorylationYPLRQTRSSGSETEQ
CCCCCCCCCCCCCEE
42.3023927012
99 (in isoform 2)Phosphorylation-42.3029743597
99 (in isoform 4)Phosphorylation-42.3024719451
100PhosphorylationPLRQTRSSGSETEQV
CCCCCCCCCCCCEEE
42.9425159151
100 (in isoform 2)Phosphorylation-42.9429743597
100 (in isoform 4)Phosphorylation-42.9424719451
102PhosphorylationRQTRSSGSETEQVVD
CCCCCCCCCCEEEEE
43.2029255136
102 (in isoform 2)Phosphorylation-43.2029743597
102 (in isoform 4)Phosphorylation-43.2024719451
104PhosphorylationTRSSGSETEQVVDFS
CCCCCCCCEEEEECC
33.1523927012
111PhosphorylationTEQVVDFSDRETKNT
CEEEEECCHHCCCCC
31.1523401153
111UbiquitinationTEQVVDFSDRETKNT
CEEEEECCHHCCCCC
31.1524816145
111 (in isoform 4)Phosphorylation-31.1524719451
113UbiquitinationQVVDFSDRETKNTAD
EEEECCHHCCCCCCC
52.8933845483
115PhosphorylationVDFSDRETKNTADHD
EECCHHCCCCCCCCC
30.4121955146
118PhosphorylationSDRETKNTADHDESP
CHHCCCCCCCCCCCC
34.7130278072
124PhosphorylationNTADHDESPPRTPTG
CCCCCCCCCCCCCCC
46.3829255136
128PhosphorylationHDESPPRTPTGNAPS
CCCCCCCCCCCCCCC
30.8623927012
130PhosphorylationESPPRTPTGNAPSSE
CCCCCCCCCCCCCCH
42.3230278072
135PhosphorylationTPTGNAPSSESDIDI
CCCCCCCCCHHCCCC
44.3130278072
136PhosphorylationPTGNAPSSESDIDIS
CCCCCCCCHHCCCCC
39.8130278072
136 (in isoform 2)Phosphorylation-39.8125056879
138PhosphorylationGNAPSSESDIDISSP
CCCCCCHHCCCCCCC
41.6423927012
141UbiquitinationPSSESDIDISSPNVS
CCCHHCCCCCCCCCC
39.4424816145
143PhosphorylationSESDIDISSPNVSHD
CHHCCCCCCCCCCCC
35.6723927012
143UbiquitinationSESDIDISSPNVSHD
CHHCCCCCCCCCCCC
35.6733845483
144PhosphorylationESDIDISSPNVSHDE
HHCCCCCCCCCCCCH
22.3423927012
148PhosphorylationDISSPNVSHDESIAK
CCCCCCCCCCHHHHH
31.6823927012
152PhosphorylationPNVSHDESIAKDMSL
CCCCCCHHHHHCCCC
33.6223927012
154UbiquitinationVSHDESIAKDMSLKD
CCCCHHHHHCCCCCC
15.8629967540
155AcetylationSHDESIAKDMSLKDS
CCCHHHHHCCCCCCC
52.9026822725
158PhosphorylationESIAKDMSLKDSGSD
HHHHHCCCCCCCCCC
42.2623927012
158 (in isoform 4)Phosphorylation-42.2624719451
160AcetylationIAKDMSLKDSGSDLS
HHHCCCCCCCCCCCC
42.4123749302
160UbiquitinationIAKDMSLKDSGSDLS
HHHCCCCCCCCCCCC
42.4125015289
162PhosphorylationKDMSLKDSGSDLSHR
HCCCCCCCCCCCCCC
38.3123401153
162 (in isoform 4)Phosphorylation-38.3124719451
164PhosphorylationMSLKDSGSDLSHRPK
CCCCCCCCCCCCCCH
39.0530266825
167PhosphorylationKDSGSDLSHRPKRRR
CCCCCCCCCCCHHHC
23.5723927012
169UbiquitinationSGSDLSHRPKRRRFH
CCCCCCCCCHHHCCH
34.7521890473
169UbiquitinationSGSDLSHRPKRRRFH
CCCCCCCCCHHHCCH
34.7521890473
170UbiquitinationGSDLSHRPKRRRFHE
CCCCCCCCHHHCCHH
29.1324816145
171AcetylationSDLSHRPKRRRFHES
CCCCCCCHHHCCHHH
59.5023749302
171UbiquitinationSDLSHRPKRRRFHES
CCCCCCCHHHCCHHH
59.5025015289
172UbiquitinationDLSHRPKRRRFHESY
CCCCCCHHHCCHHHH
37.3833845483
178PhosphorylationKRRRFHESYNFNMKC
HHHCCHHHHCCCCCC
19.4625159151
179PhosphorylationRRRFHESYNFNMKCP
HHCCHHHHCCCCCCC
22.3120068231
184SumoylationESYNFNMKCPTPGCN
HHHCCCCCCCCCCCC
37.86-
184SumoylationESYNFNMKCPTPGCN
HHHCCCCCCCCCCCC
37.86-
184UbiquitinationESYNFNMKCPTPGCN
HHHCCCCCCCCCCCC
37.8629967540
187PhosphorylationNFNMKCPTPGCNSLG
CCCCCCCCCCCCCHH
41.6125159151
192PhosphorylationCPTPGCNSLGHLTGK
CCCCCCCCHHHCCCC
39.5425159151
199UbiquitinationSLGHLTGKHERHFSI
CHHHCCCCCCCCEEE
36.7421890473
199AcetylationSLGHLTGKHERHFSI
CHHHCCCCCCCCEEE
36.7419608861
199UbiquitinationSLGHLTGKHERHFSI
CHHHCCCCCCCCEEE
36.7421890473
200UbiquitinationLGHLTGKHERHFSIS
HHHCCCCCCCCEEEE
38.3724816145
202UbiquitinationHLTGKHERHFSISGC
HCCCCCCCCEEEECC
35.5533845483
205PhosphorylationGKHERHFSISGCPLY
CCCCCCEEEECCCCC
15.1025159151
207PhosphorylationHERHFSISGCPLYHN
CCCCEEEECCCCCCC
32.9030576142
207 (in isoform 4)Phosphorylation-32.9024719451
212PhosphorylationSISGCPLYHNLSADE
EEECCCCCCCCCHHH
3.6221712546
213UbiquitinationISGCPLYHNLSADEC
EECCCCCCCCCHHHH
36.1229967540
216PhosphorylationCPLYHNLSADECKVR
CCCCCCCCHHHHHHH
38.7025159151
216 (in isoform 4)Phosphorylation-38.7025056879
221AcetylationNLSADECKVRAQSRD
CCCHHHHHHHHHHHH
32.4823749302
221UbiquitinationNLSADECKVRAQSRD
CCCHHHHHHHHHHHH
32.4829967540
228UbiquitinationKVRAQSRDKQIEERM
HHHHHHHHHHHHHHH
53.0821890473
228UbiquitinationKVRAQSRDKQIEERM
HHHHHHHHHHHHHHH
53.0821890473
229AcetylationVRAQSRDKQIEERML
HHHHHHHHHHHHHHH
52.6523749302
241UbiquitinationRMLSHRQDDNNRHAT
HHHHCCCCCCCCCCC
61.6421890473
243UbiquitinationLSHRQDDNNRHATRH
HHCCCCCCCCCCCCC
56.5833845483
250UbiquitinationNNRHATRHQAPTERQ
CCCCCCCCCCCCHHH
24.6524816145
252UbiquitinationRHATRHQAPTERQLR
CCCCCCCCCCHHHHH
13.5733845483
254UbiquitinationATRHQAPTERQLRYK
CCCCCCCCHHHHHHH
46.9821890473
258UbiquitinationQAPTERQLRYKEKVA
CCCCHHHHHHHHHHH
8.9421890473
259UbiquitinationAPTERQLRYKEKVAE
CCCHHHHHHHHHHHH
31.9423000965
261AcetylationTERQLRYKEKVAELR
CHHHHHHHHHHHHHH
44.6211922421
263AcetylationRQLRYKEKVAELRKK
HHHHHHHHHHHHHHH
42.4625953088
269AcetylationEKVAELRKKRNSGLS
HHHHHHHHHHHCCCC
69.577677559
270AcetylationKVAELRKKRNSGLSK
HHHHHHHHHHCCCCH
50.837677569
273PhosphorylationELRKKRNSGLSKEQK
HHHHHHHCCCCHHHH
45.1828176443
273UbiquitinationELRKKRNSGLSKEQK
HHHHHHHCCCCHHHH
45.1833845483
277AcetylationKRNSGLSKEQKEKYM
HHHCCCCHHHHHHHH
70.0223749302
280UbiquitinationSGLSKEQKEKYMEHR
CCCCHHHHHHHHHHH
58.2124816145
282UbiquitinationLSKEQKEKYMEHRQT
CCHHHHHHHHHHHHH
57.8633845483
293UbiquitinationHRQTYGNTREPLLEN
HHHHHCCCCHHHHHH
31.8529967540
302UbiquitinationEPLLENLTSEYDLDL
HHHHHHHCCHHCHHH
30.9733845483
308UbiquitinationLTSEYDLDLFRRAQA
HCCHHCHHHHHHHHH
40.6421890473
308UbiquitinationLTSEYDLDLFRRAQA
HCCHHCHHHHHHHHH
40.6421890473
323AcetylationRASEDLEKLRLQGQI
HHCHHHHHHHHCCCC
46.3223749302
323SumoylationRASEDLEKLRLQGQI
HHCHHHHHHHHCCCC
46.3228112733
323UbiquitinationRASEDLEKLRLQGQI
HHCHHHHHHHHCCCC
46.3229967540
331PhosphorylationLRLQGQITEGSNMIK
HHHCCCCCCCCCCEE
26.8021406692
332UbiquitinationRLQGQITEGSNMIKT
HHCCCCCCCCCCEEE
63.3533845483
334PhosphorylationQGQITEGSNMIKTIA
CCCCCCCCCCEEEEE
19.5921406692
336SulfoxidationQITEGSNMIKTIAFG
CCCCCCCCEEEEEEE
3.3921406390
338UbiquitinationTEGSNMIKTIAFGRY
CCCCCCEEEEEEECE
24.1021890473
339PhosphorylationEGSNMIKTIAFGRYE
CCCCCEEEEEEECEE
13.4524275569
355UbiquitinationDTWYHSPYPEEYARL
CCCCCCCCHHHHHHH
26.7021890473
355UbiquitinationDTWYHSPYPEEYARL
CCCCCCCCHHHHHHH
26.7021890473
368UbiquitinationRLGRLYMCEFCLKYM
HHCHHHHHHHHHHHH
1.9821890473
368UbiquitinationRLGRLYMCEFCLKYM
HHCHHHHHHHHHHHH
1.9821890473
373UbiquitinationYMCEFCLKYMKSQTI
HHHHHHHHHHHHHHH
44.4723000965
376"N6,N6-dimethyllysine"EFCLKYMKSQTILRR
HHHHHHHHHHHHHHH
36.00-
376MethylationEFCLKYMKSQTILRR
HHHHHHHHHHHHHHH
36.0023644510
376UbiquitinationEFCLKYMKSQTILRR
HHHHHHHHHHHHHHH
36.00-
382UbiquitinationMKSQTILRRHMAKCV
HHHHHHHHHHHHHHH
23.7033845483
385UbiquitinationQTILRRHMAKCVWKH
HHHHHHHHHHHHHCC
3.4621890473
385UbiquitinationQTILRRHMAKCVWKH
HHHHHHHHHHHHHCC
3.4621890473
398UbiquitinationKHPPGDEIYRKGSIS
CCCCCCHHCCCCCEE
4.8521890473
398UbiquitinationKHPPGDEIYRKGSIS
CCCCCCHHCCCCCEE
4.8521890473
399PhosphorylationHPPGDEIYRKGSISV
CCCCCHHCCCCCEEE
12.29-
403PhosphorylationDEIYRKGSISVFEVD
CHHCCCCCEEEEEEC
18.0925849741
403UbiquitinationDEIYRKGSISVFEVD
CHHCCCCCEEEEEEC
18.0923000965
405PhosphorylationIYRKGSISVFEVDGK
HCCCCCEEEEEECCC
23.5830108239
412UbiquitinationSVFEVDGKKNKIYCQ
EEEEECCCCCEEEHH
49.0233845483
414UbiquitinationFEVDGKKNKIYCQNL
EEECCCCCEEEHHHH
39.1721890473
414UbiquitinationFEVDGKKNKIYCQNL
EEECCCCCEEEHHHH
39.1721890473
418UbiquitinationGKKNKIYCQNLCLLA
CCCCEEEHHHHHHHH
2.1729967540
427UbiquitinationNLCLLAKLFLDHKTL
HHHHHHHHHCCCCCE
4.2421890473
427UbiquitinationNLCLLAKLFLDHKTL
HHHHHHHHHCCCCCE
4.2421890473
432AcetylationAKLFLDHKTLYYDVE
HHHHCCCCCEECCCH
39.6321466224
432UbiquitinationAKLFLDHKTLYYDVE
HHHHCCCCCEECCCH
39.6323000965
444UbiquitinationDVEPFLFYVMTEADN
CCHHHEEEEEECCCC
7.4621890473
448UbiquitinationFLFYVMTEADNTGCH
HEEEEEECCCCCCEE
35.6129967540
457UbiquitinationDNTGCHLIGYFSKEK
CCCCEEEEEEEECCC
1.5521890473
462UbiquitinationHLIGYFSKEKNSFLN
EEEEEEECCCCCCCC
63.9123000965
466PhosphorylationYFSKEKNSFLNYNVS
EEECCCCCCCCCCEE
42.02-
470PhosphorylationEKNSFLNYNVSCILT
CCCCCCCCCEEEEEE
21.0622817900
476 (in isoform 4)Phosphorylation-3.8324719451
477UbiquitinationYNVSCILTMPQYMRQ
CCEEEEEECHHHHHC
13.5929967540
481PhosphorylationCILTMPQYMRQGYGK
EEEECHHHHHCCCHH
6.6022817900
486PhosphorylationPQYMRQGYGKMLIDF
HHHHHCCCHHHHHHH
12.7722817900
494UbiquitinationGKMLIDFSYLLSKVE
HHHHHHHHHHHHHHH
15.8921890473
494UbiquitinationGKMLIDFSYLLSKVE
HHHHHHHHHHHHHHH
15.8921890473
506PhosphorylationKVEEKVGSPERPLSD
HHHHHHCCCCCCHHH
26.9521712546
507UbiquitinationVEEKVGSPERPLSDL
HHHHHCCCCCCHHHH
35.3721890473
507UbiquitinationVEEKVGSPERPLSDL
HHHHHCCCCCCHHHH
35.3721890473
512PhosphorylationGSPERPLSDLGLISY
CCCCCCHHHHCCEEH
33.2124732914
512UbiquitinationGSPERPLSDLGLISY
CCCCCCHHHHCCEEH
33.2123000965
524AcetylationISYRSYWKEVLLRYL
EEHHHHHHHHHHHHH
29.7026051181
524UbiquitinationISYRSYWKEVLLRYL
EEHHHHHHHHHHHHH
29.7021890473
537UbiquitinationYLHNFQGKEISIKEI
HHHHCCCCEEEHHHH
40.8823000965
540PhosphorylationNFQGKEISIKEISQE
HCCCCEEEHHHHCHH
28.79-
542UbiquitinationQGKEISIKEISQETA
CCCEEEHHHHCHHCC
42.0523000965
545PhosphorylationEISIKEISQETAVNP
EEEHHHHCHHCCCCH
24.05-
557UbiquitinationVNPVDIVSTLQALQM
CCHHHHHHHHHHHHH
24.5929967540
576 (in isoform 4)Phosphorylation-40.3024719451
587UbiquitinationLIDEWIAKEAKRSNS
HHHHHHHHHHHHHCC
49.4229967540
596AcetylationAKRSNSNKTMDPSCL
HHHHCCCCCCCHHHH
45.0830584323
601PhosphorylationSNKTMDPSCLKWTPP
CCCCCCHHHHCCCCC
28.0223401153
604AcetylationTMDPSCLKWTPPKGT
CCCHHHHCCCCCCCC
54.0426051181
606PhosphorylationDPSCLKWTPPKGT--
CHHHHCCCCCCCC--
28.2920873877
609UbiquitinationCLKWTPPKGT-----
HHCCCCCCCC-----
76.12-
611PhosphorylationKWTPPKGT-------
CCCCCCCC-------
41.3826074081

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
50SPhosphorylationKinaseATRQ13535
Uniprot
53SPhosphorylationKinaseATRQ13535
Uniprot
57SPhosphorylationKinasePLK1P53350
Uniprot
85TPhosphorylationKinaseCDK1P06493
Uniprot
88TPhosphorylationKinaseCDK1P06493
Uniprot
88TPhosphorylationKinaseCDK2P24941
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
50SPhosphorylation

18669648
50SPhosphorylation

18669648
50Subiquitylation

18669648
53SPhosphorylation

26572825
53SPhosphorylation

26572825
53Subiquitylation

26572825
57SPhosphorylation

18669648
85TPhosphorylation

18669648
88TPhosphorylation

16964243
338Kubiquitylation

23319590
432KAcetylation

-

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of KAT7_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
CEP70_HUMANCEP70physical
16189514
HOOK2_HUMANHOOK2physical
16189514
NINL_HUMANNINLphysical
16189514
BACD1_HUMANKCTD13physical
16189514
ZBT8A_HUMANZBTB8Aphysical
16189514
ANDR_HUMANARphysical
10930412
ORC1_HUMANORC1physical
10438470
ING5_HUMANING5physical
16387653
JADE1_HUMANJADE1physical
16387653
JADE2_HUMANJADE2physical
16387653
JADE3_HUMANJADE3physical
16387653
ING4_HUMANING4physical
16387653
EAF6_HUMANMEAF6physical
16387653
P53_HUMANTP53physical
17954561
CDT1_HUMANCDT1physical
18832067
JUN_HUMANJUNphysical
16880509
GEMI_HUMANGMNNphysical
16428461
CDC6_HUMANCDC6physical
16428461
ORC2_HUMANORC2physical
16428461
MCM2_HUMANMCM2physical
16428461
CD11B_HUMANCDK11Bphysical
15963510
H31_HUMANHIST1H3Aphysical
15963510
H2A2C_HUMANHIST2H2ACphysical
15963510
CDT1_HUMANCDT1physical
20980834
JADE1_HUMANJADE1physical
22144582
HAP1_HUMANHAP1physical
15383276
LRIF1_HUMANLRIF1physical
15383276
A4_HUMANAPPphysical
21832049
JADE1_HUMANJADE1physical
24739512
JADE3_HUMANJADE3physical
28514442
BRPF3_HUMANBRPF3physical
28514442
BRD1_HUMANBRD1physical
28514442
ING5_HUMANING5physical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of KAT7_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-199, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-57; THR-85; THR-88 ANDSER-102, AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-52; SER-53; SER-56;SER-57; THR-85; THR-88 AND SER-102, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-50; SER-53; SER-57;THR-85; THR-88; SER-99; SER-102 AND THR-104, AND MASS SPECTROMETRY.
"Role for Plk1 phosphorylation of Hbo1 in regulation of replicationlicensing.";
Wu Z.Q., Liu X.;
Proc. Natl. Acad. Sci. U.S.A. 105:1919-1924(2008).
Cited for: PHOSPHORYLATION AT SER-57 BY PLK1, AND PHOSPHORYLATION AT THR-85 ANDTHR-88 BY CDK1.
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-50 AND SER-57, AND MASSSPECTROMETRY.
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-50; SER-52; SER-53;SER-56 AND SER-57, AND MASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99; SER-100; SER-102;SER-124 AND THR-128, AND MASS SPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-88, AND MASSSPECTROMETRY.

TOP